Biology > STUDY GUIDE > NSG 331 Final Exam study guide 2019/2020 – Marian University | NSG331 Final Exam study guide 2019/ (All)

NSG 331 Final Exam study guide 2019/2020 – Marian University | NSG331 Final Exam study guide 2019/2020

Document Content and Description Below

NSG 331 Final Exam study guide 2019/2020 – Marian University NSG 331 Final Exam Test Plan Questions evenly distributed between modules. Dosage: 2 questions Review the case studies done by cla... ssmates before the final exam Topics Disorders Head and neck cancer Head and Neck Cancer • Incidence: o 2-3% of all malignancies o Men>women o May involve • Nasal cavity • Para-nasal sinuses • Nasopharynx • Oropharynx • Larynx • Oral cavity • Salivary glands o Most people have advance disease at time of diagnosis • Risk Factors: o Cigarette smoking (85% of cancers) o Alcohol o Occupational exposure to asbestos, wood dust, mustard gas, petroleum products o Chronic laryngitis o Voice abuse o Genetics o HPV infection o Poor oral hygiene • Manifestations o Early – vary with location of the tumor • Oral cavity – white (leukoplakia)/red (erythroplakia) patch in mouth, ulcer that does not heal, change in the fit of dentures • Lump in throat, change in quality of voice • Laryngeal - Hoarseness that lasts for more than 2 weeks • Sore throat (unilateral), otalgia (ear pain), swelling or lumps in the neck • Interprofessional Care o Diagnostic Assessment • Hx & Physical exam • Indirect pharyngoscopy and laryngoscopy • Endoscopy • Biopsy • Chest x-ray • Barium swallow • CT / MRI / PET scan o Management • Surgery • Vocal cord stripping – removal of outer layer of tissue on vocal cords (early stage) – does not change speech • Laser surgery – inserted to vaporize / remove tumor • Cordectomy – part/all vocal cords are removed (changes speech – hoarse voice(partial); loss of voice (full removal)) • Partial or total laryngectomy – removal (full or partial) of larynx • Pharyngectomy – part/all of throat is removed • Lymph node removal with neck dissection • Tracheostomy – stoma / alternate pathway • Reconstructive procedures • Radiation therapy • Chemotherapy • Targeted therapy • Physical therapy • Occupational therapy • Speech therapy Laryngectomy Laryngeal Cancer • Manifestations o Hoarseness o Pain in throat o Dysphagia o Neck masses • Diagnosis o Visual exam of larynx o Biopsy o CT/MRI o Chest x-ray o Barium swallow study • Treatment o Early: partial laryngectomy, chemo,radiation, temp. trach., soft voice o Advanced cancers: total laryngectomy, radical neck, permanent trach. Stoma. No voice, unable to smell, decr. taste Nursing management for laryngectomy • Watch for complications: o Airway obstruction o Hemorrhage – monitor VS o Carotid artery rupture o Fistula formation • Elevate HOB – decreases edema and reduces pressure on esophagus o NO FLAT BEDS • Flex neck forward • Trach/stoma care • Wound assessment/care • NG feedings – d/t location of surgery and complications of chemo and radiation Nursing diagnosis for laryngectomy o Risk for Aspiration o Ineffective Airway Clearance o Risk for Impaired Gas Exchange o Impaired Nutrition: Less than Body Requirements o Risk for Infection Artificial Larynx • Discharge teaching o Stoma care o Self tube feedings o Fluids o Humidification o Suction prn o No swimming o Shower with guard o Carry ID o Cover stoma when outside o Continue speech therapy o No smoking Video of speech after laryngectomy https://www.youtube.com/watch?v=R4azcU6i2IE Pneumonia Pneumonia Etiology • Most likely to occur when defense become incompetence or overwhelmed by the virulence or quantity of infectious agents • Organisms that cause pneumonia reach the lung by three ways: o Aspirations of normal flora from the nasopharynx or oropharynx. Many organisms that cause pneumonia are normal inhabitants of the pharynx in healthy adults o Inhalation of microbes present in the air. Examples include Mycoplasma pneumonia and fungal pneumonias o Hematogenous spread from a primary infection elsewhere in the body. Examples are streptococci and staphylococcus aureus from infective endocarditis. Pathophysiology of Pneumonia • Slightly different depending on organisms, but they all cause inflammatory response • Consolidation occurs when the normally air-filled alveoli become filled with fluid and debris • Mucus production increases Clinical Manifestations • Cough, fever, chills, dyspnea, tachypnea, and pleuritic chest pain • Cough may or may not be productive • Sputum: green, yellow, or bloody • Older adult may not have classic symptoms: o Confusion or stupor o Hypothermia rather than fever o Nonspecific manifestations: diaphoresis, anorexia, fatigue, myalgias, and HA. o Fine or coarse crackles o If consolidation occurs: ♣ Bronchial breath sounds ♣ Egophony (a change in the sounds of the voice) ♣ Increases fremitus o Patient with pleural effusion may exhibit dullness to percussion over the affected areas Classifications of Pneumonia • Causative Agents o Bacteria o Viruses o Mycoplasma organisms o Fungi o Parasites o Some chemicals • Clinical Classification o Community-acquired pneumonia (CAP) ♣ Acute infection of the lung occurring in patients who have not been hospitalized or resided in a long-term care facility within 14 days of the onset of symptoms ♣ Treatment: • At home or hospitalization depending on severity • Empiric antibiotic therapy – the initiation of treatment before definitive diagnosis or causative agent is confirmed. • Should be started as soon as CAP is suspected o Hospital-acquired pneumonia (HAP) also known as nosocomial pneumonia ♣ Ex. Ventilator-associated pneumonia (VAP) – a type of HAP, refers to pneumonia that occurs more than 48 hours after endotracheal intubation ♣ Treatment • Initiated based on risk factors, early verses late onset, and probable organism • Antibiotic therapy is adjusted after sputum culture results are back if needed • HAP and VAP are associated with longer hospital stays, increased associated costs, sicker patients, and increased risk of morbidity and mortality ♣ Major problems in treatment is multi-drug resistance organisms • Ex. Primary culprits include methicillin-resistant staphylococcus aureus and gram-negative bacilli • Other Types o Aspiration Pneumonia ♣ Conditions that increase risk • Decreased LOC (decreases gag and cough reflexes) • Difficulty swallowing • Insertion of a NG tube with or without feeding ♣ Typically more than one organism is identified on sputum culture, including aerobes and anaerobes ♣ Usually a bacterial infection ♣ Aspiration of gastric acid content causes chemical (noninfectious) pneumonitis, which may not require antibiotic therapy but secondary bacterial infections can occur 48 to 72 hours later. o Necrotizing Pneumonia ♣ Rare complication of bacterial lung infection ♣ Characterized by liquefaction and sometimes cavitation of lung tissue ♣ Causative organisms include: staphylococcus, klebsiella, and streptococcus ♣ Lung abscesses typically occur ♣ S&S: immediate respiratory insufficiency and/or failure, leukopenia, and bleeding in airways ♣ Treatment: long term antibiotic therapy and possible surgery o Opportunistic Pneumonia ♣ Inflammation and infection of the lower respiratory tract in immunocompromised patients ♣ At risk for bacterial and viral pneumonia ♣ The person may also develop an infection from micro-organisms that do not normally cause disease, such as pneumocystis jiroveci and cytomegalovirus • P. jiroveci rarely occurs in the healthy individual but is the most common from of pneumonia in people with HIV • Slow and subtle onset with symptoms of fever, tachycardia, dyspnea, nonproductive cough and hypoxemia • Chest xray shows diffuse bilateral infiltrates • Treatment consist of Bactrim, Septra either IV or orally depending on severity • CMV, a herpes virus, can cause viral pneumonia • Most are asymptomatic or mild, but severe can occur in people with impaired immune response. • Most common life threatening infectious complications after hematopoietic stem cell transplant • Treatment: anti-viral medications and high dose immunoglobulin Types of Pneumonia • Pneumocystis jiroveci pneumonia (PJP) Complications of Pneumonia • Atelectasis • Pleurisy • Pleural effusion • Bacteremia • Pneumothorax • Meningitis • Acute Respiratory Failure • Sepsis/Septic Shock • Lung abscess – not a common complication Diagnostic Studies • Chest x-ray • Sputum specimen for culture and gram stain • Blood cultures are done for the severely ill patient • ABGs • C-reactive proteins (CRP) and pro-calcitonin are being explored as possible ways to help physicians distinguish between pneumonia from cardiac and respiratory failure Interprofessional Care for Pneumonia • Pneumococcal vaccine • Prompt treatment with antibiotics is essential • Supportive care • No definitive treatment for majority of viral pneumonias • Antivirals for influenza pneumonia • Drug Therapy • Nutrition Nursing Assessment • Subjective Data o Past health history: lung cancer, COPD, diabetes, malnutrition, chronic debilitating disease o Use of antibiotics, corticosteroids, chemotherapy, or immunosuppressants o Recent abdominal or thoracic surgery o Recent intubation o Tube feedings o Smoking o Alcoholism o Respiratory infections o Nutritional intake o Activity o Dyspnea o Cough o Pain • Objective Data o Vital Signs o Oxygen saturation o Fever o Restlessness or lethargy o Splinting affected area o Tachypnea o Asymmetric chest movements o Use of accessory muscles o Crackles o Friction rub o Dullness on percussion o Increased tactile fremitus o Sputum amount and color o Tachycardia o Changes in mental status Nursing Management • Nursing diagnosis o Impaired gas exchange o Ineffective breathing pattern o Acute pain (chest) o Activity intolerance • Outcomes o Clear breath sounds o Normal breathing patterns o No signs of hypoxia o Normal chest x-ray o Normal WBC count o Absence of complications related to pneumonia Nursing Implementation • Health Promotion • Prevent pneumonia in at risk patients • Acute Care • Acute Intervention Review Questions A 56-year-old normally healthy patient at the clinic is diagnosed with bacterial community-acquired pneumonia. Before treatment is prescribed, the nurse asks the patient about an allergy to a. amoxicillin b. erythromycin c. sulfonamides d. cephalosporins The nurse is caring for a patient with pneumonia. If a pleural effusion is developing, the nurse would expect which finding? a. Barrel-shaped chest b. Paradoxical respirations c. Hyperresonance on percussion Localized decreased breath sounds Tuberculosis Tuberculosis • Infectious disease caused by Mycobacterium tuberculosis • Lungs most commonly infected • but any organ can be infected • 1/3 of world’s population has TB • Leading cause of death in patients with HIV/AIDs • Prevalence is decreasing in the United States Risk Factors for TB • Homeless • Residents of inner-city neighborhoods • Foreign-born persons • Living or working in institutions (includes health care workers) • IV injecting drug users • Poverty, poor access to health care • Immunosuppression Multi-drug resistant tuberculosis (MDR-TB) • Resistance to 2 of the most potent first-line anti-TB drugs • Extensively drug-resistant TB (XDR-TB) resistant to any fluoroquinolone plus any injectable antibiotic • Several causes for resistance occur o Incorrect prescribing o Lack of case management o Nonadherence Etiology and Pathophysiology • Spread via airborne particles • Can be suspended in air for minutes to hours • Transmission requires close, frequent, or prolonged exposure • NOT spread by touching, sharing food utensils, kissing, or other physical contact • Factors that influence the likelihood of transmission • number of organisms expelled into the air • concentration of organisms • length of time of exposure • immune system of the exposed person • https://www.youtube.com/watch?v=yR51KVF4OX0 • Once inhaled, particles lodge in bronchioles and alveoli • Local inflammatory reaction occurs • Ghon lesion or focus – represents a calcified TB granuloma (the hallmark of a primary TB infection) • Infection walled off and further spread stopped • The formation of a granuloma is a defensive mechanism aimed at walling off the infection and preventing further spread • Only 5% to 10% will develop active TB • Aerophilic (oxygen-loving) – causes affinity for lungs • Infection can spread via lymphatics and grow in other organs as well • Cerebral cortex • Spine • Epiphyses of the bone • Adrenal glands Classification • Classes - TABLE 27-8 o 0 = No TB exposure o 1 = Exposure, no infection o 2 = Latent TB, no disease o 3 = TB, clinically active o 4 = TB, not clinically active o 5 = TB suspected • Primary infection o When bacteria are inhaled and initiate an inflammatory reaction o most people’s immune system will keep them from actually developing the disease • Latent TB infection (LTBI) o Infected but no active disease o positive skin test but are asymptomatic o cannot transmit to others but can development active TB o immunosuppression, DM, poor nutrition, aging, pregnancy, stress, and chronic disease can precipitated the reactivation of LTBI • Active TB disease o Primary TB - if it develops within the first two years o Reactivation TB (post-primary) - TB disease occuring 2 years after the initial infection o if the disease is laryngeal or pulmonary, the patient is considered infectious and can transmit the disease to others. Clinical Manifestations • LTBI – asymptomatic • Pulmonary TB o Takes 2-3 weeks to develop symptoms o Initial dry cough that becomes productive o Constitutional symptoms (fatigue, malaise, anorexia, weight loss, low-grade fever, night sweats) o Dyspnea and hemoptysis late symptoms • Can also present more acutely o High fever o Chills, generalized flu-like symptoms o Pleuritic pain o Productive cough o Crackles and/or adventitious breath sounds • Extrapulmonary TB manifestations dependent on organs infected o ex. renal TB can cause dysuria and hematuria o ex. bone and joint TB may cause severe pain o ex. TB meningitis causes HA, vomiting, and lymphadenopathy • Immunosuppressed people and older adults are less likely to have fever and other signs of an infection o Carefully investigate respiratory problems in HIV patients • Rule out opportunistic diseases o A change in cognitive function may be the only initial sign of TB in an older person Complications • Appropriately treated pulmonary TB heals without complications, except for scarring and residual cavitation within the lung • Miliary TB o Large numbers of organisms spread via the bloodstream to distant organs o Fatal if untreated o Manifestations progress slowly and vary depending on which organs are infected o Fever, cough, and lymphadenopathy occur o Can include hepatomegaly and splenomegaly • Pleural TB - specific type of extrapulmonary TB o Chest pain, fever, cough, and a unilateral pleural effusion are common o Pleural effusion • Bacteria in pleural space cause inflammation. • Pleural exudates of protein-rich fluid o Empyema • Large numbers of tubercular organisms in pleural space o Diagnosis is confirmed by AFB cultures and pleural biopsy • TB pneumonia o Large amounts of bacilli discharged from granulomas into lung or lymph nodes o Manifests as bacterial pneumonia • Other organ development o Spinal destruction o Bacterial meningitis - affects central nervous system o Peritonitis Diagnostic Studies • Tuberculin skin test (TST) o AKA: Mantoux test o Uses purified protein derivative (PPD) injected intradermally o Assess for induration in 48 – 72 hours o Presence of induration (not redness) at injection site indicates development of antibodies secondary to exposure to TB • Tuberculin skin test (TST) o Positive if ≥15 mm induration in low-risk individuals o Response ↓ in immunocompromised patients • Reactions ≥5 mm considered positive o two step skin test is used to prevent misinterpretation • recommended for health care workers and for individuals who have a decreased response to allergens • Interferon-γ gamma release assays (IGRAs) o Blood tests that detects T-cells in response to Mycobacterium tuberculosis o Includes QuantiFERON-TB and T-SPOT.TB tests o Rapid results - few hours o Several advantages over TST but more expensive o one patient visit o not subject to reader bias o have no booster phenomenon o are not affected by priot bacillus Calmette-Guerin (BCG) vaccination o Chest x-ray o Cannot make diagnosis solely on x-ray o because other diseases, such as sarcoidosis, can mimic the appearance of TB o May appear normal in a patient with TB o Upper lobe infiltrates, cavitary infiltrates, lymph node involvement, and pleural and/or pericardial effusion suggest TB o Bacteriologic studies o Required for diagnosis o Consecutive sputum samples obtained on 3 different days o Stained sputum smears examined for AFB o Culture results can take up to 8 weeks o Can also examine samples from other suspected TB sites o gastric washings o CSF o fluid from effusion or abscess - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - Glipizide (Glucotrol) • Sulfonylureas • Stimulate release of insulin from pancreatic islets • Decrease glycogenolysis and gluconeogenesis • Enhance cellular sensitivity to insulin • Side effects: o Weight gain, ***HYPOGLYCEMIA Metformin (Glucophage) • Biguanides • Decreases rate of hepatic glucose production • Augments glucose uptake by tissues, especially muscles • Most effective first line treatment for type 2 DM • Side effects: o Diarrhea, lactic acidosis • Nursing considerations: o MUST BE HELD 1-2 DAYS BEFORE IV CONTRAST MEDIA GIVEN AND FOR 48 HOURS AFTER • Drug Alert: o Do not use in patients with kidney disease, liver disease, or heart failure. Lactic acidosis is rare complication of metformin accumulation. o IV contrast media that contain iodine pose a risk of acute kidney injury, which could exacerbate metformin-induced lactic acidosis o To reduce risk of kidney injury, discontinue metformin a day or two before the procedure o May be resumes 48 hours after the procedure, assuming kidney function is normal o Do not use in people who drink excessive amounts of alcohol Take with food to minimize GI side effectsDiagnostics Urinalysis: pH, specific gravity, protein, glucose, nitrites, leukocyte esterase • Urinalysis PP 1024-1031 o First morning void (more concentrated/likely to contain abnormal constituents) o Examine urine within 1 hour – otherwise keep refrigerated ♣ Bacteria multiply ♣ RBC hemolyze ♣ Casts disintegrate ♣ Urine becomes alkaline (d/t urea splitting bacteria) • Creatinine clearance – 70-135 o Collect 24-hour urine specimen ♣ First specimen in morning discarded then every void collected o Must be refrigerated, iced, or some kind of preservative o Creatinine clearance closely approximates GFR o Also, good to do a blood serum creatinine test during that time period o Most accurate indicator of renal function o Measure of amount of active muscle tissue – more muscle = higher value o After age 40 – decreases every year by 1 mL/min/year • Normal urinalysis – MEMORIZE THESE! o Clear, amber o pH: acidic (4.0-8.0) o Specific gravity: 1.03-1.030 o BUN: 8-20 o Creatinine: 0.5-1.5 o GFR-Glomerular Filtration Rate: >60 o Protein: random protein (dipstick)- 0-trace, 24-hour protein (quantitative)- <150 mg/day o Glucose: none o Nitrites: none, presence indicates bacteriuria o Leukocyte: 0-5/hpf o Esterase: none, it is an enzyme present in WBCs, indicating pyuria • Dipstick urinalysis o Identify presence of ♣ Nitrites – indicates bacteria ♣ WBC’s ♣ Leukocyte esterase - enzyme present in WBC’s that indicate pyuria – pus in urine Hemoglobin A1c – PP 1115-1118, 1659 • indicates the amount of glucose linked to hemoglobin, also called glycosylated hemoglobin • Assesses long term glycemic control during the previous 3 months • Goal is below 7% • Nursing responsibility is to inform the patient that fasting is not necessary and that blood sample will be done Cystoscopy – pp1025-1030 • Inspects interior of bladder with a tubular lighted scope • UseS: insert ureteral catheters, remove calculi, obtain biopsies of bladder lesions, treat bleeding lesions • Lithotomy position is used • Procedure may be done using local or general anesthesia, depending on patient’s needs and condition • Complications include urinary retention, urinary tract hemorrhage, bladder infection and perforation of bladder • Nursing responsibility o Before: force fluids or give IV fluids if general anesthesia is to be used, ensure consent is signed, explain procedure, give preoperative medication. o After: explain that burning on urination, pink-tinged urine, and urinary frequency are expected effects. • Observe for bright red bleeding, which is not normal. Assist with ambulation because orthostatic hypotension may occur. Offer warm sitz baths, heat, & mild analgesics to relieve discomfort. • Endourologic procedures for stones • Flexible ureteroscope inserted to remove stones from renal pelvis/UUT • Endoscopic procedure – inspects interior side of the bladder – inserted through urethra • Can remove calculi, obtain biopsy specimens, treat bleeding lesions • Fluids usually given before the procedure – often give meds before as well • Burning during urination can occur after the procedure, urine can have a pink tinge, or inc frequency • Also, could have orthostatic hypotension o • Trousseau’s sign – p 284 • Positive Trousseau’s (B & C) or Chvostek’s (A) sign = Tetany o • Carpal spasm induced by inflating BP cuff above systolic BP for a few min • Tests for HYPOCALCEMIA, also for hypomagnesemia Chvostek’s sign – P 284 • Rxn of facial muscle to light touch to facial nerve in front of the ear – facial muscles contract • Tests for HYPOCALCEMIA, also for hypomagnesemia CBC: WBC, Hgb, Htc, platelets, Red blood cell (RBC) – PP 599-600 • WBC: 4000-1100, elevations aver 1100 indicate infection, inflammation, tissue injury, death and malignancies, count less than 4000 is associated w/ bone marrow depression, severe or chronic illness • Hgb: female 11.7-15.5 g/dL, male 13.2-17.3 g/dL, measurement of gas-carrying capacity of RBC, reduced in cases of anemia, hemorrhage, and hemodilution (fluid excess), increased in polycythemia, hemoconcentration (fluid deficit/dehydration) • Hct: female 35-47%, male 39-50 %, measurement of packed cell volume of RBCs expressed as a percentage of the total blood volume • Platelets: 150,000-400,000 (150-400x10^9) • RBC: female 3.8-5.1x10^6, male 4.3-5.7x10^6 Prostate needle biopsy – PP1275-1281 • Needed to confirm the diagnosis of prostate cancer • Typically done using a transrectal approach • US probe enables urologist to visualize abnormalities where biopsy needles are to be placed into the prostate • Suspicious area is located, biopsy needles inserted through rectum wall into prostate to obtain tissue samples Fasting blood glucose pp1115-1118 • 70-99 mg/dL • Measures circulating glucose levels • Before: patient should fast 8-12 hours, water intake is permitted • Many medications may influence results Postprandial blood glucose • Variant of dumping syndrome o Uncontrolled gastric emptying of a bolus of fluid high in carbs into the small intestine o Results in hyperglycemia and release of excess insulin which leads to reflex hypoglycemia o 2 Hours after eating – symptoms similar to any hypoglycemic reaction Computed Tomography (CT)- p 603 • Noninvasive radiologic examination using computer assisted x-ray • Contrast medium often is used in abdominal studies of liver or spleen • Before: investigate iodine sensitivity if contrast medium is used (shellfish allergy), IV and or oral contrast may be given prior to procedure depending on area being studied. o Patient may need to be NPO 4 hours prior to study, assess renal function before test. • After: encourage patient to drink fluids to avoid renal problems with contrast, if ordered. Blood urea nitrogen (BUN) – p 1026 • 6-20 mg/dL, 2.1-7.1 mmol/L • Used to detect renal problems • Increased BUN indicates impaired kidney function • Concentration of urea in the blood is regulated by rate at which kidney excretes urea • Non-renal factors may increase BUN o rapid cell destruction from infections o Fever o GI bleeding, trauma o Athletic activity o Excessive muscle breakdown. • Explain test and watch for post puncture bleeding. Creatinine – P 1026 • 0.6-1.3 mg/Dl • More reliable than BUN as a determinant of renal function • Increased levels indicate impaired renal function • End product of muscle and protein metabolism and is released at a constant rate • Explain test and watch for post puncture bleeding. Prothrombin time (PT) / International normalized ratio (INR) • Prothrombin Time – P 601: 11-16 sec, assessment of extrinsic coagulation • INR – P 601: 2-3 is desired therapeutic level with warfarin • Blood Lab Tests o Diagnostic Test o Normal Range o Activated clotting time (ACT) o 70-120 sec o Activated partial thromboplastin time (aPTT) o 25-35 sec o International normalized ratio (INR) o 2-3 o Hemoglobin o F: 11.7-15.5 g/dL; M: 13.2-17.3 g/dL o Hematocrit o F: 35-47%; M: 39-50% o Platelet count o 150,000-400,000 µL o D-dimer o <250 mcg/L o Fibrin monomer complex o <6.1 mg/L • Potassium 3.5-5 mEq Sodium – 135-145 mEq Arterial Blood Gas Values (ABGs) • Normal: MEMORIZE THESE!!! o pH: 7.35-7.45 o pCO2: 35-45 o pO2: 80-100 o HCO3: 22-26 • Diagnose in six steps: o Evaluate pH o Analyze PaCO2 o Analyze HCO3 o Determine if CO2 or HCO3 matches the alteration o Decide if the body is attempting to compensate o Evaluate PaO2 = If abnormal – hypoxemia is present • Acid/Base Mnemonic – ROME o Respiratory - Opposite ♣ Alkalosis: Incr. pH, Decr. PaC02 ♣ Acidosis: Decr. pH, Incr. PaCO2 o Metabolic - Equal ♣ Alkalosis: Incr. pH, Incr. HCO3 ♣ Acidosis: Decr. pH, Decr. HCO3 • ABG’s with Compensation o Resp. Acidosis: Incr. HCO3 o Respiratory Alkalosis: Decr. HCO3 o Metabolic Acidosis: Decr. CO2 o Metabolic Alkalosis: Incr. CO2 o Compensatory change is always in the same direction as the pathologic (primary) change. ♣ Partial compensation - pH will not be wi/in normal range ♣ Complete compensation - pH will be back to normal Albumin – p 273 • 3.5-5.0 g/dL • If albumin level is low, likely to see edema in patient (oncotic pressure) • Indicates malnourishment – impairs ability to bind/distribute drugs, bind calcium Alanine aminotransferase (ALT) – p 852 • 10-40 U/L, elevated in liver damage and inflammation TNM classification • Anatomic extent of disease involvement – solid tumors (i.e. not leukemia) o T = tumor size and invasiveness o N = Presence/absence of spread to lymph nodes o M = Metastasis to distant organ sites o o Tis = Tumor in situ – no tendency to invade or metastasize o Done at the completion of diagnostic workup to guide effective treatment o Surgical staging – staging done at surgical excision, exploration, and/or lymph node sampling [Show More]

Last updated: 1 year ago

Preview 1 out of 171 pages

Add to cart

Instant download

document-preview

Buy this document to get the full access instantly

Instant Download Access after purchase

Add to cart

Instant download

Reviews( 0 )

$16.50

Add to cart

Instant download

Can't find what you want? Try our AI powered Search

OR

REQUEST DOCUMENT
40
0

Document information


Connected school, study & course


About the document


Uploaded On

Jul 04, 2020

Number of pages

171

Written in

Seller


seller-icon
Martin Freeman

Member since 4 years

485 Documents Sold


Additional information

This document has been written for:

Uploaded

Jul 04, 2020

Downloads

 0

Views

 40

Document Keyword Tags

More From Martin Freeman

View all Martin Freeman's documents »

Recommended For You

Get more on STUDY GUIDE »

$16.50
What is Browsegrades

In Browsegrades, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.

We are here to help

We're available through e-mail, Twitter, Facebook, and live chat.
 FAQ
 Questions? Leave a message!

Follow us on
 Twitter

Copyright © Browsegrades · High quality services·